Optimization of packaging of adeno-associated virus gene therapy vectors using plasmid transfections

Adeno-associated Virus (AAV) is attracting wide attention as a potential human gene therapy vector. The advantages of this vector system are that it is naturally defective, it readily integrates into the target cell's genome and is considered to be nonpathogenic. AAV infects a wide variety of cell and tissue types. The major disadvantages of the vector are its small size and the labor-intensive procedures required to prepare large amounts of the vector for clinical studies. In this manuscript we have systematically tested a number of variables in the packaging procedure to determine the optimal conditions for successful vector preparation. Using an AAV vector that expresses the green fluorescent protein and the most commonly used packaging plasmid, pAAV/Ad, we determined the optimal conditions for; lysis of the transfected cultures, ratio of packaging to vector plasmids, day of harvest after transfection, storage conditions, multiplicity of infection of helper adenovirus, and the time of adenovirus infection. These results have important relevance for investigators that are using AAV vectors for heterologous gene transfer studies. (C) 1998 Elsevier Science B.V. All rights reserved.